Gustave Roussy at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Gustave Roussy brings 5 presentations to ENA 2026 in Barcelona. Its program centres on precision oncology and new methods for early drug trials, including AI agents in clinical trials. It also covers MTA-cooperative PRMT5 inhibitors for cancers with MTAP loss and how DNA damage tolerance pathways shape mutations caused by tobacco carcinogens.
| Organization | ENA 2026 Attendance |
|---|---|
Gustave Roussy Villejuif, France | |
Comprehensive cancer centre combining patient care, research and teaching, with an early-phase drug development department. | Session Thu Nov 19 10–11:30am Talk Thu Nov 19 3–3:20pm Session Fri Nov 20 9:30–10:45am Talk Fri Nov 20 10:15–10:30am Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from Gustave Roussy
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction